Massy Z - Search Results

1

Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.

Guigonis V, Frémeaux-Bacchi V, Giraudier S, Favier R, Borderie D, Massy Z, Mougenot B, Rosenblatt DS, Deschênes G. Guigonis V, et al. Among authors: massy z. Am J Kidney Dis. 2005 Mar;45(3):588-95. doi: 10.1053/j.ajkd.2004.12.004. Am J Kidney Dis. 2005. PMID: 15754282

2

Increased plasma S-nitrosothiol levels in chronic haemodialysis patients.

Massy ZA, Borderie D, Nguyen-Khoa T, Drüeke TB, Ekindjian OG, Lacour B. Massy ZA, et al. Nephrol Dial Transplant. 2003 Jan;18(1):153-7. doi: 10.1093/ndt/18.1.153. Nephrol Dial Transplant. 2003. PMID: 12480974

3

Increased pasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: a prospective study.

Massy ZA, Fumeron C, Borderie D, Tuppin P, Nguyen-Khoa T, Benoit MO, Jacquot C, Buisson C, Drüeke TB, Ekindjian OG, Lacour B, Iliou MC. Massy ZA, et al. J Am Soc Nephrol. 2004 Feb;15(2):470-6. doi: 10.1097/01.asn.0000106716.22153.bb. J Am Soc Nephrol. 2004. PMID: 14747395

4

Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.

Jungers P, Joly D, Massy Z, Chauveau P, Nguyen AT, Aupetit J, Chadefaux B. Jungers P, et al. Among authors: massy z. Nephrol Dial Transplant. 1999 Dec;14(12):2903-6. doi: 10.1093/ndt/14.12.2903. Nephrol Dial Transplant. 1999. PMID: 10570095

5

Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy.

Touam M, Zingraff J, Jungers P, Chadefaux-Vekemans B, Drüeke T, Massy ZA. Touam M, et al. Among authors: massy za. Kidney Int. 1999 Dec;56(6):2292-6. doi: 10.1046/j.1523-1755.1999.00792.x. Kidney Int. 1999. PMID: 10594808 Free article. Clinical Trial.

6

Vascular calcification in chronic kidney disease.

Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N; Vascular Calcification Work Group. Goodman WG, et al. Among authors: massy z. Am J Kidney Dis. 2004 Mar;43(3):572-9. doi: 10.1053/j.ajkd.2003.12.005. Am J Kidney Dis. 2004. PMID: 14981617 Review. No abstract available.

7

Pulmonary hypertension in CKD.

Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C. Bolignano D, et al. Among authors: massy z. Am J Kidney Dis. 2013 Apr;61(4):612-22. doi: 10.1053/j.ajkd.2012.07.029. Epub 2012 Nov 17. Am J Kidney Dis. 2013. PMID: 23164943 Review.

8

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Ramezani A, et al. Am J Kidney Dis. 2016 Mar;67(3):483-98. doi: 10.1053/j.ajkd.2015.09.027. Epub 2015 Nov 15. Am J Kidney Dis. 2016. PMID: 26590448 Free PMC article. Review.

9

Changing bone patterns with progression of chronic kidney disease.

Drüeke TB, Massy ZA. Drüeke TB, et al. Kidney Int. 2016 Feb;89(2):289-302. doi: 10.1016/j.kint.2015.12.004. Kidney Int. 2016. PMID: 26806832 Free article. Review.

10

The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.

Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, Pecoits-Filho R, Lopes AA, Yamagata K, Wada T, Wong MM, Speyer E, Port FK, Pisoni RL, Robinson BM. Mariani L, et al. Am J Kidney Dis. 2016 Sep;68(3):402-13. doi: 10.1053/j.ajkd.2016.03.414. Epub 2016 Apr 22. Am J Kidney Dis. 2016. PMID: 27113505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters